NanoViricides, Inc. (NNVC)

CIK 0001379006 · Healthcare · Biotechnology

Recent Filing Index

Form Filed Qtr End F_Period 8K: Earnings Release
Latest Q3-2026 —
Q2-2026 —
Q1-2026 —
Latest FY-2025 —
Q3-2025 —
Q2-2025 —
Q1-2025 —
FY-2024 —
Q3-2024 —
Q2-2024 —
Q1-2024 —
FY-2023 —

Filing Summary

Report Name | Notes Fiscal Period (Annual) Fiscal Period (Quarter)
Document and Entity Information
Statements
Balance Sheet
Balance Sheet (P)
Statements of Operations
Statement of Changes In Stockholders' Equity
Statement of Changes In Stockholders' Equity (P)
Statements of Cash Flows
Notes
Accrued Expenses
Award Timing Disclosure
—
Commitments and Contingencies
Common Stock Warrants
Cybersecurity Risk Management and Strategy Disclosure
—
Equity Transactions
Income Tax Provision
—
Insider Trading Arrangements
Insider Trading Policies and Procedures
—
Intangible Assets
Liquidity
Liquidity and Going Concern
Loan Payable
—
Organization and Nature of Business
Pay Vs Performance Disclosure
Property and Equipment
Related Party Transactions
Subsequent Events
Summary of Significant Accounting Policies